INTRODUCTIONChronic hepatitis virus B or C infection results in damage to hepatocytes and may eventually lead to liver fibrosis, cirrhosis and/or hepatocellular carcinoma [1][2][3] . The diagnosis of liver fibrosis and cirrhosis in patients with chronic virus hepatitis is of therapeutic and prognostic importance.Although histologic examination of percutaneous biopsy specimens is the gold criterion for the severity of fibrosis and cirrhosis, biopsy is invasive and cannot be used repeatedly in follow-up. Moreover, liver biopsy can yield false negative results in nearly 20-30% of cases [4][5][6][7] . Therefore, it is important to use noninvasive methods in differentiation between liver fibrosis and cirrhosis.Ultrasonography (US) is a noninvasive and inexpensive procedure for diagnosis of focal and diffuse parenchymal disease of liver. Although US cannot detect minute changes, it can show liver cirrhosis in patients with decompensated liver function [8][9][10][11] . However, correlation between US and histologic diagnosis has not been fully investigated in large series of patients. We conducted a prospective study to evaluate the validity of US for diagnosis of liver fibrosis in patients with chronic liver hepatitis without clinical or biochemical evidence of cirrhosis. Abstract AIM: To evaluate the validity of ultrasonographic and pathologic diagnosis of liver fibrosis in patients with chronic viral hepatitis.
MATERIALS AND METHODS
Patients
METHODS:The liver fibrosis status in 324 patients was evaluated by both needle biopsy and ultrasonography. Liver fibrosis was divided into S0 -S4 stages. S4 stage was designated as definite cirrhosis. The ultrasonographic examination included qualitative variables, description of liver surface and parenchyma, and quantitative parameters, such as diameter of vessels, blood flow velocity and spleen size.